| Source HCPCS Code |
|
Target NDC Code |
J3262
Injection, tocilizumab, 1 mg
|
⇄
|
50242-0135-01
ACTEMRA 80 MG/4 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J3262
|
⇄
|
50242-0135-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J3262
Injection, tocilizumab, 1 mg
|
⇄
|
50242-0136-01
ACTEMRA 200 MG/10 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J3262
|
⇄
|
50242-0136-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J3262
Injection, tocilizumab, 1 mg
|
⇄
|
50242-0137-01
ACTEMRA 400 MG/20 ML VIAL
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
J3262
|
⇄
|
50242-0137-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J3262
Injection, tocilizumab, 1 mg
|
⇄
|
50242-0138-01
ACTEMRA 162 MG/0.9 ML SYRINGE
|
| Detail Information |
| Relationship Start Date |
11/06/2013 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.9 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J3262
Injection, tocilizumab, 1 mg
|
⇄
|
50242-0143-01
ACTEMRA ACTPEN 162 MG/0.9 M
|
| Detail Information |
| Relationship Start Date |
01/07/2019 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.9 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J3262
Tocilizumab injection
|
⇄
|
50242-0135-01
Actemra
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J3262
Tocilizumab injection
|
⇄
|
50242-0136-01
Actemra
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J3262
Tocilizumab injection
|
⇄
|
50242-0137-01
Actemra
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|